Loading...
•
Mar 31, 2022
Health Catalyst Q1 2022 Earnings Report
Health Catalyst began the year by achieving strong performance across its business, including exceeding the mid-point of its quarterly guidance for both revenue and Adjusted EBITDA.
Key Takeaways
Health Catalyst reported strong first quarter results, exceeding revenue and Adjusted EBITDA guidance. The company achieved positive Adjusted EBITDA, fulfilling a commitment made at the time of its IPO.
Total revenue for the quarter was $68.09 million, a 22% increase year-over-year.
Technology revenue increased by 25% year-over-year to $42.23 million.
Professional services revenue increased by 17% year-over-year to $25.86 million.
Adjusted EBITDA was $671 thousand, compared to a loss of $837 thousand in the same quarter last year.
Revenue by Segment
Forward Guidance
For the second quarter of 2022, Health Catalyst expects total revenue between $68.0 million and $71.0 million, and Adjusted EBITDA between $(1.5) million and $0.5 million. For the full year of 2022, the company expects total revenue between $287.8 million and $292.8 million, and Adjusted EBITDA between $(4.0) million and $(2.0) million.
Positive Outlook
- Total revenue between $68.0 million and $71.0 million for Q2 2022
- Adjusted EBITDA between $(1.5) million and $0.5 million for Q2 2022
- Total revenue between $287.8 million and $292.8 million for the full year 2022
- Adjusted EBITDA between $(4.0) million and $(2.0) million for the full year 2022
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...